PharmaVOICE - 
February 2019
Purchase Issue
In Every Issue
Letter from the Editor
Agile Transformation By definition change is hard, and anyone who [...]
By

Taren Grom, Editor

Upfront
Bayer Ups its Pledge for Science Learning Experiments For Children [...]
By

PharmaVOICE Staff

Health Tech
POPS! Blood Glucose Test Attaches To Smartphone Trend Watch: Medical [...]
By

PharmaVOICE Staff

Innovator’s Corner
Harnessing the Power of the Body’s Electrical System Frank Amato, [...]
By

Frank Amato, CEO, electroCore

Artificial Intelligence
Bayer Uses AI to Boost Pharmacovigilance Trend Watch: Pharma Use [...]
By

PharmaVOICE Staff

Last Word
Defining Your Career Path Dagmar Rosa-Björkeson, chief strategy and corporate [...]
By

Dagmar Rosa-Björkeson, Chief Strategy and Corporate Development Officer, Mallinckrodt Pharmaceuticals

On The Cover

Transformation: Ready, Set, Agile
According to McKinsey, companies that have enterprise agility share some commonalities: a North Star-mentality, in other words an overarching customer strategy; a scalable team structure; a rapid decision-making mentality; a dynamic people model that ignites passion; and a willing adoption of next-generation technologies. In today’s environment, one in which companies find themselves having to transition [...]
By

PharmaVOICE Staff

Features

SHOWCASE: Outsourcing – M&A on the Rise
Pharmaceutical outsourcing remains big business, as companies cut internal costs and with the rise of smaller specialist companies focused on rare diseases and genomics-based therapies. The move to outsource is growing, with reports that companies are turning to partners more now than they did five years ago. This has led to a steep rise in [...]
By

PharmaVOICE Staff

Outsourcing Regulatory Filings with an FTE Model: Five Keys to Consider
As an increasing number of drug and device developers focus their efforts on reducing costs so they can invest more heavily in their core R&D functions, it’s no surprise that the outsourcing market for healthcare regulatory affairs is predicted to expand at a rapid pace over the next decade. Some estimates say the market will [...]
By

Clareece West, VP and General Manager, Cardinal Health Regulatory Sciences

SHOWCASE: Rare Disease: Rare Difficulties: Finding Cures and Tackling Costs
The day-to-day lives of people with rare diseases is often poorly understood. And those with rare diseases face many challenges. Whether it’s going to work or studying, completing daily tasks such as preparing meals and shopping, or simply managing their health, the impact disease has on patients can be overwhelming. Since the Orphan Drug Act [...]
By

PharmaVOICE Staff

Raising One Voice for the Millions Impacted by Rare Disease
Next-generation technologies in medicine have opened new doors for identifying rare diseases and developing better and more targeted rare disease treatments. Remarkable advancements in global research efforts have already made an impact on the lives of patients living with hundreds of rare disease types, especially due to the recent exponential growth in approved treatment options [...]
By

Meredith Gartner, Senior Project Manager, Advanced Clinical

Is the Rare Disease Business Model Here to Stay?
These days, the term “rare disease” is well ingrained in our everyday vernacular — but that hasn’t always been the case. The pharmaceutical industry paid little attention to developing new treatments for rare disease prior to the Reagan Administration’s implementation of the Orphan Drug Act (ODA) in 1983, which provided incentives for pharmaceutical companies to [...]
By

Scott D. Hibbard, Group Director Oncology/Hematology, Beacon Healthcare Communications

From Scientific Discovery to Real World Application: the “Future” of Medicine is Here
I vividly remember the day in February of 2001 when the nearly complete sequence of the human genome was first published. My cellular and molecular biology professor had unfolded a giant poster from the journal Nature and revealed those approximately 30,000 genes to our class. Amazingly, in less than two decades since that seminal moment [...]
By

Jahda Hill, Ph.D., Senior Scientific Director, Dudnyk

Executive Perspective: A Fused Model for the Enterprise – A Conversation with Brian Williams
Winning in today’s digital era requires more than just apps and a website. Fusing an enterprise for success in the digital era requires companies to seamlessly collaborate across the enterprise and create a true strategic pathway for a better customer experience. Recently, Cognizant commissioned a comprehensive study conducted by Forrester to test the hypothesis that [...]
By

Brian Williams, Chief Digital Officer and Global Life Sciences Consulting Leader, Cognizant

Red Zone: Disruptive Innovation: Questions for the C-Suite
It is not the strongest of the species that survives, nor is it the most intelligent. It is the one that is most adaptable to change. Whether a direct quote from Charles Darwin or a summary of his writings, this statement is perhaps the most profound scientific explanation of life itself, in all its shapes, [...]
By

Srini Shankar, Vice President, Life Sciences, Cognizant

FEEDBACK